ENTITY
Livzon Pharmaceutical Group

Livzon Pharmaceutical Group (1513 HK)

66
Analysis
Health CareChina
Livzon Pharmaceutical Group Inc. develops and manufactures pharmaceutical products, including chemical medicines, bio-chemical medicines, biological engineering medicines, chemical compound crude medicines, antibiotics, micro-ecological preparations, patent Chinese medicines, and diagnosis reagents etc.
more
Refresh
24 Feb 2020 21:13

Full Circulation Of H Shares: Signs Of Life

On the 29 December 2017, the China Securities Regulatory Commission's ("CSRC") announced it would launch the H-share Full Circulation Pilot...

Logo
382 Views
Share
bullishMSCI ACWI Index
22 Nov 2019 05:57

Global Equity Strategy: Health Care Hitting On All Cylinders - Overweight

Global equities remain in a short-term consolidation phase, however we continue to believe the longer-term trend is up and to the right for the...

Logo
386 Views
Share
bullishChina Tower
19 Nov 2019 18:28

CSRC Green Lights Full Circulation Of H Shares

Back in June last year, I flagged (Legend's Conversion of Domestic Shares) 850mn shares entering Legend Holdings Corp H (3396 HK)'s share registry...

Logo
804 Views
Share
23 Sep 2019 10:59

HK Connect Ideas: First Weekly Outflows in 19 Weeks, SMIC, Auto Sector (2019-09-20)

In our weekly HK Connect Snippet series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as...

Logo
358 Views
Share
09 Sep 2019 13:53

HK Connect Ideas: Highlight of Stock Adjustment Effective Today

In our weekly HK Connect Snippet series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as...

Logo
348 Views
Share
x